About us

Entopsis, the developers of PCRopsis™ Next Gen Direct PCR, was founded in 2011 to reimagine diagnostics with impactful and low-cost solutions that approach problems from unconventional perspectives. We are predominantly focused in the areas of oncology and infectious diseases. Entopsis is proud to have established strategic academic and industry collaborations with renowned companies and institutions. We are greatly thankful for the support of Peter Thiel's Breakout Labs.

Who's behind PCRopsis™ ?

We are a team of scientists & engineers who see the world for what it can be